GlaxoSmithKline Stock Forecast
Green day on Friday for GlaxoSmithKline stock after gaining 0.346%
(Updated on May 03, 2024)
The GlaxoSmithKline stock price gained 0.346% on the last trading day (Friday, 3rd May 2024), rising from $43.35 to $43.50. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 0.95% from a day low at $43.27 to a day high of $43.68. The price has risen in 8 of the last 10 days and is up by 9.43% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 4 million shares were bought and sold for approximately $153.28 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Given the current short-term trend, the stock is expected to fall -2.42% during the next 3 months and, with a 90% probability hold a price between $38.13 and $42.45 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
GSK Signals & Forecast
Mostly positive signals in the chart today. The GlaxoSmithKline stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $42.07 and $41.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 10.77%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for GlaxoSmithKline stock
GlaxoSmithKline finds support from accumulated volume at $42.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.410 (0.95%) between high and low. For the last week, the stock has had daily average volatility of 1.35%.
Our recommended stop-loss: $42.15 (-3.10%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 11 days ago.)
Trading Expectations (GSK) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect GlaxoSmithKline PLC to open at $43.48, and during the day (based on 14 day Average True Range), to move between $42.86 and $44.14, which gives a possible trading interval of +/-$0.644 (+/-1.48%) up or down from last closing price. If GlaxoSmithKline PLC takes out the full calculated possible swing range there will be an estimated 2.96% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $43.58 (0.18%) than the support at $42.02 (3.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is GlaxoSmithKline PLC stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.
Current score: 3.133 Buy Candidate Unchanged
Predicted Opening Price for GlaxoSmithKline PLC of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $43.48 ( 0.0383%) | $43.50 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for GSK
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 43.89 | 0.90 % | |
| R2 | 43.74 | 0.544 % | ||
| R1 | 43.64 | 0.322 % | ||
| Current price: | 43.50 | |||
| Support | S1 | 43.33 | -0.398 % | |
| S2 | 43.23 | -0.621 % | ||
| S3 | 43.07 | -0.98 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0 | . | |
| R2 | 0 | . | ||
| R1 | 43.58 | 0.184 % | ||
| Current price | 43.50 | |||
| Support | S1 | 42.02 | -3.40% | |
| S2 | 41.94 | -3.59% | ||
| S3 | 41.80 | -3.91% |
GSK Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | May 16, 2024 | May 16, 2024 | Jul 11, 2024 | $0.369 | 0.85% |
| 2 | Feb 01, 2024 | Feb 22, 2024 | Apr 11, 2024 | $0.399 | 0.98% |
| 3 | Nov 01, 2023 | Nov 16, 2023 | Jan 11, 2024 | $0.340 | 0.86% |
| 4 | Jul 26, 2023 | Aug 17, 2023 | Oct 12, 2023 | $0.361 | 0.98% |
| 5 | Apr 26, 2023 | May 18, 2023 | Jul 13, 2023 | $0.348 | 1.00% |
FAQ
Click here for our free guide on how to buy GlaxoSmithKline Stock.
